Tsai N - Search Results

1

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.

Liaw YF, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, Myers RP, Brown RS Jr, Jeffers L, Tsai N, Bialkowska J, Tang S, Beebe S, Cooney E. Liaw YF, et al. Among authors: tsai n. Hepatology. 2011 Jul;54(1):91-100. doi: 10.1002/hep.24361. Hepatology. 2011. PMID: 21503940 Clinical Trial.

2

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

Fong TL, Han SH, Tsai NC, Morgan TR, Mizokami M, Qian D, Phan C, Goad K, Redeker AG. Fong TL, et al. Among authors: tsai nc. J Hepatol. 1998 Mar;28(3):369-74. doi: 10.1016/s0168-8278(98)80308-5. J Hepatol. 1998. PMID: 9551672 Clinical Trial.

3

Chronic hepatitis B: a critical appraisal of current approaches to therapy.

Perrillo RP, Gish RG, Peters M, Keeffe EB, Alberti A, Buti M, Cooksley WG, Fried MW, Hadziyannis SJ, Liaw YF, Naoumov NV, Schiff ER, Thio CL, Tsai N, Schalm S. Perrillo RP, et al. Among authors: tsai n. Clin Gastroenterol Hepatol. 2006 Feb;4(2):233-48. doi: 10.1016/s1542-3565(05)00983-3. Clin Gastroenterol Hepatol. 2006. PMID: 16469685

4

Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks.

Sherman M, Yurdaydin C, Simsek H, Silva M, Liaw YF, Rustgi VK, Sette H, Tsai N, Tenney DJ, Vaughan J, Kreter B, Hindes R; AI463026 Benefits of Entecavir for Hepatitis B Liver Disease (BEHoLD) Study Group. Sherman M, et al. Among authors: tsai n. Hepatology. 2008 Jul;48(1):99-108. doi: 10.1002/hep.22323. Hepatology. 2008. PMID: 18537189 Clinical Trial.

5

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

Chang TT, Lai CL, Kew Yoon S, Lee SS, Coelho HS, Carrilho FJ, Poordad F, Halota W, Horsmans Y, Tsai N, Zhang H, Tenney DJ, Tamez R, Iloeje U. Chang TT, et al. Among authors: tsai n. Hepatology. 2010 Feb;51(2):422-30. doi: 10.1002/hep.23327. Hepatology. 2010. PMID: 20049753 Clinical Trial.

6

Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.

Manns MP, Akarca US, Chang TT, Sievert W, Yoon SK, Tsai N, Min A, Pangerl A, Beebe S, Yu M, Wongcharatrawee S. Manns MP, et al. Among authors: tsai n. Expert Opin Drug Saf. 2012 May;11(3):361-8. doi: 10.1517/14740338.2012.653340. Epub 2012 Jan 11. Expert Opin Drug Saf. 2012. PMID: 22233350 Clinical Trial.

7

High rates of viral suppression after long-term entecavir treatment of Asian patients with hepatitis B e antigen-positive chronic hepatitis B.

Pan CQ, Tong M, Kowdley KV, Hu KQ, Chang TT, Lai CL, Yoon SK, Lee SS, Cohen D, Tang H, Tsai N. Pan CQ, et al. Among authors: tsai n. Clin Gastroenterol Hepatol. 2012 Sep;10(9):1047-1050.e1. doi: 10.1016/j.cgh.2012.03.016. Epub 2012 Apr 1. Clin Gastroenterol Hepatol. 2012. PMID: 22475742 Clinical Trial.

8

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective.

Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T. Tsai N, et al. Clinicoecon Outcomes Res. 2012;4:227-35. doi: 10.2147/CEOR.S31784. Epub 2012 Aug 23. Clinicoecon Outcomes Res. 2012. PMID: 22977309 Free PMC article.

9

Long-term therapy with nucleoside/nucleotide analogues for chronic hepatitis B in Asian patients.

Pan CQ, Hu KQ, Tsai N. Pan CQ, et al. Among authors: tsai n. Antivir Ther. 2013;18(7):841-52. doi: 10.3851/IMP2481. Epub 2012 Nov 23. Antivir Ther. 2013. PMID: 23178555 Review.

10

JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients.

Pockros PJ, Jensen D, Tsai N, Taylor R, Ramji A, Cooper C, Dickson R, Tice A, Kulkarni R, Vierling JM, Lou Munson M, Chen YC, Najera I, Thommes J; JUMP-C Investigators. Pockros PJ, et al. Among authors: tsai n. Hepatology. 2013 Aug;58(2):514-23. doi: 10.1002/hep.26275. Epub 2013 Jun 24. Hepatology. 2013. PMID: 23359491 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page